Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 45.28
-2.02 (-4.27%)
Oct 21, 2026, 3:59 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 38.84 billion as of October 20, 2026. It is the 3,601st most valuable company in the world and the 183rd biggest in Hong Kong. Its market cap has increased by 308.61% in one year.
Market Cap
38.84B
Enterprise Value
38.43B
Revenue
1.96B
Global Rank
Country Rank
#183 Hong Kong
PE Ratio
47.70
ChartMarket Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 38.84B, an increase of 276.59%. That is a compound annual growth rate of 37.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 38.84B | 64.69% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 93.50B |
| Akeso | 84.10B |
| Genscript Biotech | 75.94B |
| RemeGen | 55.18B |
| 3SBio | 36.06B |
| Shanghai Junshi Biosciences | 31.16B |
| Shanghai Henlius Biotech | 28.00B |
| InnoCare Pharma | 25.93B |